Secondary failure of TNF-α inhibitors in clinical practice-Reference-Cited by-同舟云学术

Secondary failure of TNF-α inhibitors in clinical practice

Published:2018-11-18 Issue:1 Volume:32 Page:e12760
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Owczarczyk-Saczonek Agnieszka¹^ORCID,Owczarek Witold²,Osmola-Mańkowska Agnieszka³,Adamski Zygmunt³,Placek Waldemar¹,Rakowska Adriana⁴

Affiliation:

1. Department of Dermatology, Sexually Transmitted Diseases and Clinical Immunology; The University of Warmia and Mazury; Olsztyn Poland

2. Department of Dermatology; Military Institute of Medicine; Warsaw Poland

3. Department of Dermatology; University of Medical Sciences; Poznan Poland

4. Department of Dermatology; Medical University of Warsaw; Warsaw Poland

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dth.12760/fullpdf

Reference36 articles.

1. An evidence-based review of certolizumab pegol in the treatment of active psoriatic arthritis: Place in therapy;Acosta-Felquer;Open Access Rheumatology,2016

2. Anti-infliximab antibody status and its relation to clinical response in psoriatic patients: A pilot study;Adisen;The Journal of Dermatology,2010

3. Tumor necrosis factor inhibitors: Clinical implications of their different immunogenicity profiles;Anderson;Seminars in Arthritis and Rheumatism,2005

4. Impact of immunogenicity on response to anti-TNF therapy in moderate-to-severe plaque psoriasis: Results of the PREDIR study;Ara-Martín;The Journal of Dermatological Treatment,2017

5. Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up;Bartelds;JAMA,2011

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PDE4 Gene Family Variants Are Associated with Response to Apremilast Treatment in Psoriasis;Genes;2024-03-17

2. Long-term efficacy and safety of netakimab in patients with active ankylosing spondylitis: results of three years of use in the international multicentre, randomized, double-blind, phase III clinical trial BCD-085-5/ASTERA;Modern Rheumatology Journal;2024-02-17

3. Long-Term Durability of Certolizumab Pegol in Patients with Rheumatoid Arthritis Over 5 Years: An Analysis of Pooled Clinical Trial Data;Rheumatology and Therapy;2023-02-27

4. Proinflammatory cytokines and their receptors as druggable targets to alleviate pathological pain;Pain;2022-11

5. Dynamics of Type I and Type II Interferon Signature Determines Responsiveness to Anti-TNF Therapy in Rheumatoid Arthritis;Frontiers in Immunology;2022-06-06